Ulcerative Colitis
VSL#3® in the Dietary Management of Active Ulcerative Colitis
A recent study concluded that 77% of the patients consuming VSL#3® for the dietary management of active ulcerative colitis had a positive response to the product with no adverse events.3
Images used with permission from Dr. Richard N. Fedorak, M.D., University of Alberta
VSL#3® in the Dietary Management of Ulcerative Colitis (Adapted from Venturi et. al. 1999)
In a study with VSL#3® in dietary management of UC patients intolerant or allergic to 5-ASA, 75% of patients had a positive response to the product for 12 months.66
Original Articles of VSL#3® in the Dietary Management of UC
Tursi A et al: Med Sci Monit 2004;10:PI126-131.
Bibiloni R et al: Am J Gastroenterology 2005;100:1-8..
Venturi A et al: Ailment Pharmacol Ther 1999; 13:1103-1108.
